EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Virtual Screening of Anti-HIV Leads from Mayana (Coleus scutellarioides Benth.) Phytoconstituents

Von Jay Maico G. Gabucan

Pharmaceutical Fronts · 01.12.2025 · 07 (04) · e337-e347

DOI: 10.1055/a-2731-9183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Fronts, erschienen am 01.12.2025. Verfasst von Von Jay Maico G. Gabucan. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While some Coleus species have demonstrated anti-HIV activity, the potential of Mayana (Coleus scutellarioides Benth.) remains largely unexplored. This study therefore aimed to investigate the anti-HIV potential of phytoconstituents from Mayana using in silico methods. Phytochemicals from Mayana were identified using gas chromatography–mass spectrometry and their binding affinity against HIV-1 integrase (IN), protease (PR), and reverse transcriptase (RT) were evaluated through molecular docking simulations. In this work, a total of 32 individual compounds were identified. Stigmasterol was found to have the highest binding affinity to HIV IN (−8.571 kcal/mol) and HIV PR (−10.250 kcal/mol), whereas caryophyllene showed the highest affinity to HIV RT (−9.625 kcal/mol). These compounds also demonstrated multitarget interactions, suggesting potential inhibitory effects. However, compared with synthetic drugs such as amprenavir (−9.421 kcal/mol for PR), raltegravir (−9.825 kcal/mol for IN), and nevirapine (−9.748 kcal/mol for RT), the phytoconstituents had lower binding affinities. Pharmacokinetic predictions revealed that the top-ranked phytochemicals conform to Lipinski's Rule of Five, indicating favorable drug-like properties. Overall, Mayana contains bioactive phytoconstituents with promising affinity for key HIV-1 enzymes, supporting the potential of Mayana as a source of novel anti-HIV leads. However, further in vitro and in vivo studies are needed to confirm the efficacy, safety, and pharmacokinetic profile.

Zitieren

APA

Gabucan, V. J. M. G. (2025). Virtual Screening of Anti-HIV Leads from Mayana (Coleus scutellarioides Benth.) Phytoconstituents. Pharmaceutical Fronts, 07(04), e337-e347. https://doi.org/10.1055/a-2731-9183

Vancouver

Gabucan VJMG. Virtual Screening of Anti-HIV Leads from Mayana (Coleus scutellarioides Benth.) Phytoconstituents. Pharmaceutical Fronts. 2025;07(04):e337-e347. doi:10.1055/a-2731-9183

BibTeX
@article{Gabucan2025,
  author = {Gabucan, Von Jay Maico G.},
  title = {Virtual Screening of Anti-HIV Leads from Mayana (Coleus scutellarioides Benth.) Phytoconstituents},
  journal = {Pharmaceutical Fronts},
  year = {2025},
  volume = {07},
  number = {04},
  pages = {e337--e347},
  doi = {10.1055/a-2731-9183}
}
Kostenlos starten →